• Something wrong with this record ?

Distribution of pathogenic variants in the CFTR gene in a representative cohort of people with cystic fibrosis in the Kingdom of Bahrain

OAK. Majed, FO. Majed, NJ. Almoamen, HB. Alsatrawi, SD. Shehabi, J. Hrbková, M. Libik, M. Macek

. 2024 ; 299 (1) : 52. [pub] 20240514

Language English Country Germany

Document type Journal Article

Grant support
IP00064203/6003 Ministerstvo Zdravotnictví Ceské Republiky
LM2018132 Ministerstvo Školství, Mládeže a Tělovýchovy
CG-2015-104643 Vertex Pharmaceuticals

E-resources Online Full text

NLK ProQuest Central from 2000-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2005-03-01 to 1 year ago
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago

BACKGROUND: Cystic fibrosis (CF) is a rare multi-systemic recessive disorder. The spectrum and the frequencies of CFTR mutations causing CF vary amongst different populations in Europe and the Middle East. In this study, we characterised the distribution of CF-causing mutations (i.e. pathogenic variants in the CFTR gene) in a representative CF cohort from the Kingdom of Bahrain based on a three-decade-long analysis at a single tertiary centre. We aim to improve CF genetic diagnostics, introduce of CF neonatal screening and provide CFTR modulator therapy (CFTRm). METHODS: CFTR genotyping and associated clinical information were drawn from a longitudinal cohort. We sequenced 56 people with CF (pwCF) that had one or both CFTR mutations unidentified and carried out comprehensive bioinformatic- and family-based segregation analyses of detected variants, including genotype-phenotype correlations and disease incidence estimates. The study methodology could serve as a basis for other non-European CF populations with a high degree of consanguinity. RESULTS: Altogether 18 CF-causing mutations were identified, 15 of which were not previously detected in Bahrain, accounting for close to 100% of all population-specific alleles. The most common alleles comprise c.1911delG [2043delG; 22.8%], c.2988+1G > A [3120+1G>A; 16.3%], c.2989-1G>A [3121-1G>A; 14.1%], c.3909C>G [N1303K; 13.0%], and c.1521_1523delCTT [p.PheF508del; 7.6%]. Although the proportion of 1st cousin marriages has decreased to 50%, the frequency of homozygosity in our pwCF is 67.4%, thereby indicating that CF still occurs in large, often related, families. pwCF in Bahrain present with faltering growth, pancreatic insufficiency and classical sino-pulmonary manifestations. Interestingly, two pwCF also suffer from sickle cell disease. The estimated incidence of CF in Bahrain based on data from the last three decades is 1 in 9,880 live births. CONCLUSION: The most commonCF-causing mutations in Bahraini pwCF were identified, enabling more precise diagnosis, introduction of two-tier neonatal screening and fostering administration of CFTRm.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013936
003      
CZ-PrNML
005      
20240905133838.0
007      
ta
008      
240725s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00438-024-02119-4 $2 doi
035    __
$a (PubMed)38744777
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Majed, Osama A Karim $u Salmaniya Medical Complex, Rd. No. 2904, Manama, Kingdom of Bahrain. osama_ka@hotmail.com $u Royal University of Surgeons in Ireland, Medical University of Bahrain, Al Sayh Muharraq Governorate, Busaiteen, Kingdom of Bahrain. osama_ka@hotmail.com
245    10
$a Distribution of pathogenic variants in the CFTR gene in a representative cohort of people with cystic fibrosis in the Kingdom of Bahrain / $c OAK. Majed, FO. Majed, NJ. Almoamen, HB. Alsatrawi, SD. Shehabi, J. Hrbková, M. Libik, M. Macek
520    9_
$a BACKGROUND: Cystic fibrosis (CF) is a rare multi-systemic recessive disorder. The spectrum and the frequencies of CFTR mutations causing CF vary amongst different populations in Europe and the Middle East. In this study, we characterised the distribution of CF-causing mutations (i.e. pathogenic variants in the CFTR gene) in a representative CF cohort from the Kingdom of Bahrain based on a three-decade-long analysis at a single tertiary centre. We aim to improve CF genetic diagnostics, introduce of CF neonatal screening and provide CFTR modulator therapy (CFTRm). METHODS: CFTR genotyping and associated clinical information were drawn from a longitudinal cohort. We sequenced 56 people with CF (pwCF) that had one or both CFTR mutations unidentified and carried out comprehensive bioinformatic- and family-based segregation analyses of detected variants, including genotype-phenotype correlations and disease incidence estimates. The study methodology could serve as a basis for other non-European CF populations with a high degree of consanguinity. RESULTS: Altogether 18 CF-causing mutations were identified, 15 of which were not previously detected in Bahrain, accounting for close to 100% of all population-specific alleles. The most common alleles comprise c.1911delG [2043delG; 22.8%], c.2988+1G > A [3120+1G>A; 16.3%], c.2989-1G>A [3121-1G>A; 14.1%], c.3909C>G [N1303K; 13.0%], and c.1521_1523delCTT [p.PheF508del; 7.6%]. Although the proportion of 1st cousin marriages has decreased to 50%, the frequency of homozygosity in our pwCF is 67.4%, thereby indicating that CF still occurs in large, often related, families. pwCF in Bahrain present with faltering growth, pancreatic insufficiency and classical sino-pulmonary manifestations. Interestingly, two pwCF also suffer from sickle cell disease. The estimated incidence of CF in Bahrain based on data from the last three decades is 1 in 9,880 live births. CONCLUSION: The most commonCF-causing mutations in Bahraini pwCF were identified, enabling more precise diagnosis, introduction of two-tier neonatal screening and fostering administration of CFTRm.
650    _2
$a lidé $7 D006801
650    12
$a protein CFTR $x genetika $7 D019005
650    12
$a cystická fibróza $x genetika $7 D003550
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a mutace $7 D009154
650    _2
$a novorozenec $7 D007231
650    _2
$a dítě $7 D002648
650    _2
$a novorozenecký screening $7 D015997
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kojenec $7 D007223
650    _2
$a genotyp $7 D005838
650    _2
$a genetické asociační studie $x metody $7 D056726
650    _2
$a mladiství $7 D000293
650    _2
$a alely $7 D000483
650    _2
$a kohortové studie $7 D015331
650    _2
$a dospělí $7 D000328
651    _2
$a Bahrajn $7 D001445
655    _2
$a časopisecké články $7 D016428
700    1_
$a Majed, Fatema Osama $u Royal University of Surgeons in Ireland, Medical University of Bahrain, Al Sayh Muharraq Governorate, Busaiteen, Kingdom of Bahrain
700    1_
$a Almoamen, Nabeel Jasim $u Salmaniya Medical Complex, Rd. No. 2904, Manama, Kingdom of Bahrain
700    1_
$a Alsatrawi, Husain Baqer $u Salmaniya Medical Complex, Rd. No. 2904, Manama, Kingdom of Bahrain
700    1_
$a Shehabi, Salma Dawood $u Department of Pediatrics, University Hospital in Coventry and Warwickshire, Coventry, United Kingdom
700    1_
$a Hrbková, Jana $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czechia
700    1_
$a Libik, Malgorzata $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czechia
700    1_
$a Macek, Milan $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine and Motol University Hospital, Charles University, Prague, Czechia $1 https://orcid.org/0000000251735280
773    0_
$w MED00006446 $t Molecular genetics and genomics $x 1617-4623 $g Roč. 299, č. 1 (2024), s. 52
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38744777 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133832 $b ABA008
999    __
$a ok $b bmc $g 2143629 $s 1225802
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 299 $c 1 $d 52 $e 20240514 $i 1617-4623 $m Molecular genetics and genomics $n Mol Genet Genomics $x MED00006446
GRA    __
$a IP00064203/6003 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a LM2018132 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a CG-2015-104643 $p Vertex Pharmaceuticals
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...